News

Categories
Uncategorized

AIQ SOLUTIONS AT IMMUNO-ONCOLOGY 360° 2021

AIQ Solutions will be attending Immuno-Oncology 360° from February 23rd through 26th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions, and our treatment response quantification and prediction technology.

Categories
Uncategorized

AIQ SOLUTIONS AT ASCO GENITOURINARY CANCERS SYMPOSIUM 2021

AIQ Solutions will be attending ASCO Genitourinary Cancers Symposium from February 11th through 13th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions, and our treatment response quantification and prediction technology.

Categories
Uncategorized

VISIT AIQ SOLUTIONS AT 2022 ASCO GENITOURINARY CANCERS SYMPOSIUM BOOTH #36

Australian Privacy Policy AIQ's software has been cleared for clinical use under 510(k) K173444. For details, including the applicable Indications for Use, see: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K173444